Menu
A community from npj Precision Oncology

Nature Research Cancer Community

  • Register
  • Sign In
Go to the profile of Nick Tobin

Nick Tobin

Associate Professor, Karolinska Institute
Follow
  • Karolinska Institute
  • Members
  • Sweden
  • Profile
  • Content 1

Popular Content

Pan-cancer analysis of genomic aberrations in relation to cell cycle activity levels
Contributor Oncogene
Behind the paper

Pan-cancer analysis of genomic aberrations in relation to cell cycle activity levels

Go to the profile of Nick Tobin
Nick Tobin
Jun 24, 2020

Topics

Channels contributed to:

Behind the paper

This community is not edited and does not necessarily reflect the views of Nature Research. Nature Research makes no representations, warranties or guarantees, whether express or implied, that the content on this community is accurate, complete or up to date, and to the fullest extent permitted by law all liability is excluded.

  • Community Policy
  • Website Terms of Use
  • Report Content
  • Cookie Policy
  • Online Privacy Notice
Copyright © 2021 Springer Nature All rights reserved. Powered by Zapnito.
Nature Research Cancer Community
Nature Research Cancer Community
  • Home
  • Channels
    • Back
    • About the community
    • From the editors
    • News and Opinion
    • Behind the paper
    • On the road
    • Pan-Cancer Project
    • Gallery
    • TRACERx
    • COVID-19
    • Black in cancer
    • After the Paper
  • Rooms
  • Q & A
  • People
    • Back
    • Contributors
    • Members
    • Nature Research Staff
    • Editors
  • Cancer at Nature Research
  • Sponsor
  • Account
  • Register
  • Sign In
  • Social
  • Twitter
We use cookies to help improve your experience. By continuing to browse our website you are consenting to our use of cookies.
Learn more

Please sign in or register for FREE

Sign in to Nature Research Cancer Community

Lost your password? Resend confirmation
Or sign in via
LinkedIn Twitter

Register to Nature Research Cancer Community

Nature Research Cancer Community is for all those interested in cancer research, including our journal readers and authors, educators, and those working in medicine, industry and healthcare

Register